Nicholas Kadysh

Nicholas Kadysh appears in our data through filings on Pharmala Biotech Holdings Inc. shares, published by SEDI. Between 22 March 2021 and 27 July 2026, the trades on record add up to 15 filings.

Purchases make up the whole of the open-market record (3 purchases, €20k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant and 7 option exercises.

A typical purchase (the median) is worth €4,223. No cluster: in 3 purchases, no other insider of the company bought within 30 days.

The record was last updated on 29 July 2026 with a share grant in Pharmala Biotech Holdings Inc. The latest purchase dates back some time: it was published 1,310 days ago, on 28 March 2023. Typically, a trade is published a median of 2 days after it takes place. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.